Common Stock, Shares, Issued of Kairos Pharma, LTD. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Kairos Pharma, LTD. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Kairos Pharma, LTD. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 20,821,353, a 62% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Kairos Pharma, LTD. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 20,821,353 +7,974,568 +62% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 17,743,765 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 15,825,118 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 13,736,597 +3,173,957 +30% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 12,846,785 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q4 2023 10,562,640 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.